Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [68Ga]Ga-PentixaFor PET/CT

Background CXCR4-directed positron emission tomography/computed tomography (PET/CT) has been used as a diagnostic tool in patients with solid tumors. We aimed to determine a potential correlation between tumor burden and radiotracer accumulation in normal organs. Methods Ninety patients with histolo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular imaging and biology 2022-08, Vol.24 (4), p.659-665
Hauptverfasser: Serfling, Sebastian E., Lapa, Constantin, Dreher, Niklas, Hartrampf, Philipp E., Rowe, Steven P., Higuchi, Takahiro, Schirbel, Andreas, Weich, Alexander, Hahner, Stefanie, Fassnacht, Martin, Buck, Andreas K., Werner, Rudolf A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background CXCR4-directed positron emission tomography/computed tomography (PET/CT) has been used as a diagnostic tool in patients with solid tumors. We aimed to determine a potential correlation between tumor burden and radiotracer accumulation in normal organs. Methods Ninety patients with histologically proven solid cancers underwent CXCR4-targeted [ 68 Ga]Ga-PentixaFor PET/CT. Volumes of interest (VOIs) were placed in normal organs (heart, liver, spleen, bone marrow, and kidneys) and tumor lesions. Mean standardized uptake values (SUV mean ) for normal organs were determined. For CXCR4-positive tumor burden, maximum SUV (SUV max ), tumor volume (TV), and fractional tumor activity (FTA, defined as SUV mean x TV), were calculated. We used a Spearman's rank correlation coefficient (ρ) to derive correlative indices between normal organ uptake and tumor burden. Results Median SUV mean in unaffected organs was 5.2 for the spleen (range, 2.44 – 10.55), 3.27 for the kidneys (range, 1.52 – 17.4), followed by bone marrow (1.76, range, 0.84 – 3.98), heart (1.66, range, 0.88 – 2.89), and liver (1.28, range, 0.73 – 2.45). No significant correlation between SUV max in tumor lesions (ρ ≤ 0.189, P  ≥ 0.07), TV (ρ ≥ -0.204, P  ≥ 0.06) or FTA (ρ ≥ -0.142, P  ≥ 0.18) with the investigated organs was found. Conclusions In patients with solid tumors imaged with [ 68 Ga]Ga-PentixaFor PET/CT, no relevant tumor sink effect was noted. This observation may be of relevance for therapies with radioactive and non-radioactive CXCR4-directed drugs, as with increasing tumor burden, the dose to normal organs may remain unchanged.
ISSN:1536-1632
1860-2002
DOI:10.1007/s11307-022-01717-1